Oncotelic Therapeutics, Inc. Deferred Tax Assets, State Taxes
Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Assets, State Taxes of $2.06 million as of 2023-12-31, per its 10-K filed 2024-04-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsStateTaxes · last filed 2024-04-12
- 2023-12-31: Deferred Tax Assets, State Taxes $2.06M.
- 2022-12-31: Deferred Tax Assets, State Taxes $2.15M.
- 2021-12-31: Deferred Tax Assets, State Taxes $2.25M.
- 2021-09-30: Deferred Tax Assets, State Taxes $2.20M.
| Period end | Deferred Tax Assets, State Taxes | Deferred Tax Assets, State Taxes as first filed |
|---|---|---|
| 2023-12-31 | $2.06M 10-K · filed 2024-04-12 | |
| 2022-12-31 | $2.15M 10-K · filed 2024-04-12 | |
| 2021-12-31 | $2.25M 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $2.20M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $2.17M 10-Q · filed 2021-08-20 | |
| 2021-03-31 | $2.14M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $2.09M 10-K · filed 2022-04-15 | $2.09K 10-K · filed 2021-04-15 |